NCT07258329 Screening for Intrapartum Fetal Compromise Using Placental Biomarkers
| NCT ID | NCT07258329 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Pregnant Women |
| Study Type | OBSERVATIONAL |
| Enrollment | 428 participants |
| Start Date | 2025-03-28 |
| Primary Completion | 2028-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 428 participants in total. It began in 2025-03-28 with a primary completion date of 2028-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the association between placental markers (sFlt-1, PlGF, and the sFlt-1/PlGF ratio) and intrapartum fetal compromise, assessed on the basis of the cardiotocographic tracing.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Gestational age ≥ 32 weeks * Obtaining informed consent for participation in the study and for the processing of personal data * Pregnant patients with an indication to perform placental marker testing as part of routine clinical practice * Patients who will deliver at the Obstetrics Units of the participating centers Exclusion Criteria: \- Absolute contraindications to vaginal delivery (placenta previa, vasa previa, placenta accreta, previous myomectomy)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07258329 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pregnant Women. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07258329 currently recruiting?
Yes, NCT07258329 is actively recruiting participants. Contact the research team at antonio.farina@unibo.it for enrollment information.
Where is the NCT07258329 trial being conducted?
This trial is being conducted at Bologna, Italy, Milan, Italy.
Who is sponsoring the NCT07258329 clinical trial?
NCT07258329 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 428 participants.